Superior Planning, LLC’s Royalty Pharma RPRX Stock Holding History

Superior Planning, LLC’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.28K	Buy	+39	New	+$2.3K	﹤0.01%	1517

Other funds holding RPRX

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Royal London Asset Management United Kingdom $54.5B AUM 31.87% 1-Year Est. Return

Superior Planning, LLC's RPRX Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Royalty Pharma (RPRX) in Q3 2026: 39 shares worth $2.28K. The stake represents ﹤0.01% of the portfolio and ranks #1517 among its holdings.

484 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

Superior Planning, LLC held 39 shares of Royalty Pharma worth $2.28K as of Q3 2026.
Royalty Pharma was a new Superior Planning, LLC position in Q3 2026.
Royalty Pharma made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #1517 holding.
484 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.